CD226 and B-cell chronic lymphocytic leukemia: Furthermore, we could not obtain a larger blood sample size to conduct more in‐depth analyses, such as RNAseq or single‐cell RNAseq, on different CD226+ and CD226−CD8+ T cell subsets from CLL patients.